Paclitaxel and 5-fluorouracil in metastatic breast cancer: The US experience

Seminars in Oncology

Volumn 23, Issue 1 SUPPL. 1, 1996, Pages 48-52

  Paul, D M ^a   Garrett, A M ^a   Meshad, M ^a   DeVore, R D ^a   Porter, L L ^a   Johnson, D H ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; PACLITAXEL;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MIDDLE AGED; PACLITAXEL; REMISSION INDUCTION;

EID: 0029963971     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)